v3.26.1
FAIR VALUE MEASUREMENTS AND DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables)
 6 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Company's population of financial assets and liabilities subject to fair value measurements
The Company’s population of financial assets and liabilities subject to fair value measurements were as follows:
Fair Value Measurements
Condensed Consolidated Balance Sheets Classification
June 30, 2026
Fair Value atUsing Fair Value Hierarchy
June 30, 2026Level 1Level 2Level 3
Noncontrolling interest putNoncontrolling interest$16.4 $— $16.4 $— 
Cross currency swaps
Other liabilities
$268.8 $— $268.8 $— 
Interest rate swaps
Other liabilities
$56.9 $— $56.9 $— 
Cash surrender value of life insurance policiesOther assets, net$106.8 $— $106.8 $— 
Deferred compensation assetOther assets, net$64.8 $— $64.8 $— 
Deferred compensation liability
Other liabilities
$164.8 $— $164.8 $— 
Contingent considerationAccrued expenses and other/Other liabilities$95.5 $— $— $95.5 
Fair Value Measurements
Condensed Consolidated Balance Sheets Classification
December 31, 2025
Fair Value atUsing Fair Value Hierarchy
December 31, 2025Level 1Level 2Level 3
Noncontrolling interest putNoncontrolling interest$16.9 $— $16.9 $— 
Cross currency swaps
Other liabilities
$274.0 $— $274.0 $— 
Interest rate swaps
Other liabilities
$52.7 $— $52.7 $— 
Cash surrender value of life insurance policiesOther assets, net$99.6 $— $99.6 $— 
Deferred compensation assetOther assets, net$53.1 $— $53.1 $— 
Deferred compensation liability
Other liabilities
$150.5 $— $150.5 $— 
Contingent considerationAccrued expenses and other/Other liabilities$50.0 $— $— $50.0 
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
Fair Value Measurement of Level 3 Liabilities:Contingent Consideration
Balance at December 31, 2025$50.0 
Additions from business acquisitions, excluding measurement period adjustments89.8 
Cash payments(30.5)
Other adjustments(13.8)
Balance at June 30, 2026$95.5 
(1)
(1)At June 30, 2026, $38.1 and $57.4 of contingent consideration is included within Accrued expenses and other and Other liabilities, respectively, in the Company’s Condensed Consolidated Balance Sheets.
Derivative Instruments, Gain (Loss) [Table Text Block]
The table below provides information regarding the location and amount of pretax (losses) gains of derivatives designated in fair value hedging relationships:
Amounts Included In Other Comprehensive Loss
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Cross currency swaps$— $(155.3)$5.2 $(148.3)